Week of February 13, 2022

Facebook  Instagram  LinkedIn  Twitter  YouTube


Center for Disaster Medicine Presents Operational Medicine Course for Law Enforcement 


CDM hosted a two-day course on Operational Medicine for law enforcement. Participants included 16 officers from the FBI, Homeland Security and local police departments from Mount Vernon, Mount Pleasant, Bedford, White Plains, City of Rye, Hastings-on-Hudson, Irvington and the Village of Mamaroneck. Officers were trained in didactic topics in basic tactical medicine, including sensory-impaired environments, direct threat care, indirect threat care and evacuation care. Read the full article on the CDM Operational Course and view the photo gallery. 

Film Screening and Discussion Helps Celebrate Black History Month

The NYMC community gathered to view the documentary, Aftershock, and engaged in in-depth discussion on the U.S. maternal health crisis on February 9, in recognition of Black History Month. The documentary examined the preventable deaths of two young Black women in New York City due to childbirth complications and followed their bereaved families who fought for justice and galvanized activists, birth workers and physicians to reckon with the U.S. maternal health crisis. The event was hosted by the Office of Diversity and Inclusion, Christian Medical and Dental Association, Obstetrics and Gynecology Student Interest Group, Student National Medical Association and the Universal Health Club. Read the full article on the movie screening and discussion.

Envisioning the Healthcare Landscape with ChatGPT

NYMC explores the opportunities and risks of artificial intelligence (AI) on the healthcare industry in the following article written entirely using ChatGPT. The healthcare industry is continuing to transform and adapt, driven in part by the advent of new technologies and innovations, including AI. An emerging technology that is poised to change the healthcare landscape, along with so many other industries, is ChatGPT. This AI-powered chatbot is designed to provide instant, accurate information and support to patients. While the technology offers exciting new opportunities, there are also risks associated with incorporating ChatGPT into the healthcare system that must be assessed, as well as ethical and legal considerations to be taken into account. Read the full article on IA and ChatGPT. 


Comorbidities and Hospital Length of Stay Key Mortality Predictors After Blunt Thoracic Trauma

Blunt thoracic trauma is responsible for 35 percent of trauma-related deaths in the United States and significantly contributes to morbidity and health care-related financial strain. A newly published study conducted by Guy Elgar, SOM Class of 2025, and Abbas Smiley, M.D., research assistant professor of surgery, found that comorbidities were a greater factor influencing mortality in emergently admitted patients with blunt chest wall trauma than advanced age, as had been reported in previous studies. Read the full article on blunt thoracic trauma.


Felipe C. Cabello, M.D., professor emeritus of pathology, microbiology and immunology, was an invited speaker at a virtual session on January 19, organized by ReAct, a global network dedicated to the problem of antimicrobial resistance, and its North American host, the Department of International Health at the Johns Hopkins Bloomberg School of Public Health. The session focused on the need to develop and implement policies for greater transparency on antimicrobial use in aquaculture. In his presentation, "Aquaculture and antimicrobial resistance and One Health," Dr. Cabello discussed the molecular epidemiology of antimicrobial resistance in aquaculture and its relevance for human and animal health and the environment. 

Pan African flag

Test your knowledge on NYMC’s proud history of diversity and inclusion on Instagram during Black History Month. 


Fawaz Al-Mufti, M.D., associate professor of neurology, neurosurgery and of radiology, received a $172,517 grant from Cerus Endovascular, Inc. for "NECC: US IDE Study of the Contour NEurovasCular System™ for IntraCranial Aneurysm Repair."

Mitchell Cairo, M.D., professor of pediatrics, medicine, cell biology and anatomy and of pathology, microbiology and immunology, received a $1,004,658 grant from AbbVie Inc. for "A Single Arm, Open-Label, Phase 1b Trial of Epcoritamab in Pediatric Patients with Relapsed/ Refractory Aggressive Mature B-cell Neoplasms.” 

HeePeel Chang, M.D., clinical assistant professor of surgery, received a $5,000 grant from the Society for Vascular Surgery for "Efficacy and Safety of Intravascular Lithotripsy in Treatment of Chronic Limb-Threatening Ischemia."

George Coritsidis, M.D., professor of medicine, received a $7,000 grant from Natera, Inc., for "Renasight Testing in Underserved immigrant population with CKD of unknown etiology from Central and South America."

Victor Garcia, Ph.D., assistant professor of pharmacology, received a $56,000 grant for "Interdisciplinary Basic Medical School Sciences Program" and a $16,000 grant for "MAP to Success: A Medical Application Preparation Program at New York Medical College (NYMC)" from the Association of Medical Schools.

Jessica Hochberg, M.D., associate professor of pediatrics, received a $9,500 grant from CHOP for “ADVL1711 A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including CNS Tumors.”

David Kronn, M.D., associate professor of pediatrics and of pathology, microbiology and immunology, received a $845,000 grant from Sanofi, Inc., for "Baby-COMET: Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa."

Delong Liu, M.D., Ph.D., professor of medicine, received a $41,516 grant from MorphoSys for “REAL-MIND: Prospective multicenter observational study of patients with relapsed or refractory diffuse large B-cell lymphoma starting second- or third-line therapy and not receiving autologous stem cell transplant.”

Srihari Naidu, M.D., professor of medicine, received a $92,211 grant from Cytokinetics, Inc. for “Protocol CY 6031 A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate The Efficacy And Safety Of CK3773274 in Adults With Symptomatic Hypertrophic Cardiomyopathy nd Left Ventricular Outflow Tract Obstruction.”

Sheila Nolan, M.D., assistant professor of pediatrics, received a $22,096 grant from the NIH for "Comparative Effectiveness and Complications of Intravenous Ceftriaxone Compared with Oral Doxycycline in Lyme Meningitis in Children.”

Lance Parton, M.D., professor of pediatrics and associate professor of anesthesiology and of obstetrics and gynecology, received a $50,000 grant from the NIH for "Safety of Sildenafil in Premature Infants with Severe Bronchopulmonary Dysplasia (SILDI-SAFE).”


Tana Pradhan, D.O., clinical associate professor of obstetrics and gynecology, received a $103,545 grant from K-Beta Group, Inc/GOG Foundation for "A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with Malignant Tumors Harboring DNA Repair and Cell Cycle Gene Alternations (Protocol ZN-c3-005)."

Karen Seiter, M.D., professor of medicine, received a $85,935 grant for "Tamibarotene in Combination with Venetoclax and Azacitidine in Previously Untreated Adult Patients Selected for RARA-positive AML Who Are Ineligible for Standard Induction Therapy” and a $65,620 grant for "A Randomized, Double-blind, Placebo-controlled Phase 3 Study of Tamibarotene Plus Azacitidine Versus Placebo Plus Azacitidine in Newly Diagnosed, Adult Patients Selected for RARA-positive Higher-risk Myelodysplastic Syndrome" (SELECT MDS-)" from Syros Pharma/CRO Precision for Medicine.

Gregory Veillette, M.D., assistant professor of surgery, received a $117,449 grant from Imvax, Inc. for "Evaluation of Immunological Responses Against Hepatocellular Carcinoma (Hcc) Tumors.”

John Welter, M.D., assistant professor of pediatrics, received a $288,790 grant from AbbVie for “A Phase 2 Study of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation” and a $195,118 grant from Vertex Pharmaceuticals for “A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of Vx-121 Combination Therapy in Subjects with Cystic Fibrosis.”

Steven Wolf, M.D., clinical professor of pediatrics, received a $15,040 grant from Eisai for “Extended Access Program and Retrospective Chart Review For Locaserin in Dravet Syndrome and Other Refractory Epilepsies."


red heart with NYMC in the middle

NYMC Goes Red

Wednesday, February 15, 2023 • 12:15 p.m.

Willner Lobby, MEC

Wear red to show your support for National Heart Month by joining the NYMC community for a group photo.

2023 HeLa Diversity, Equity and Inclusion Conference

Wednesday, February 22, 2023 • 2:00 p.m.

Nevins Auditorium, MEC

The Office of Diversity and Inclusion is presenting a discussion on how to address health inequities in our community.

Community Read - Teeth: The Story of Beauty, Inequality, and the Struggle for Oral Health in America

Wednesday, February 22, 2023 • 5:15 p.m.

19 Skyline Drive, Room 407 (TCDM Exam Room)

The Phillip Capozzi, M.D., Library, the Office of Diversity and Inclusion, and the Touro College of Dental Medicine are hosting a community read and book discussion in honor of Black History Month.

SOM Seeks MMI Interviewers


The SOM Office of Admissions is seeking interviewers for the Multiple Mini-Interview (MMI) 2023-24 interview season. 





Monday, February 13

12:00 p.m.

Department of Physiology Seminar

5:30 p.m.

Graduate School of Biomedical Sciences Sessions

Wednesday, February 15

9:30 a.m.

Department of Neurology and Neurosurgery

Grand Rounds

12:00 p.m.

Department of Medicine Grand Rounds

12:15 p.m.

National Heart Month: NYMC Goes Red Group Photo

Add an event to the NYMC calendar here.

Visit nymc.edu/calendar to view all events.


NYMC Leadership News

What Removing COVID's 'Public Health Emergency' Status Means For You

Huffington Post - 2/6/2023

Robert W. Amler, M.D., M.B.A., dean of SHSP and vice president for government affairs

Nachum And Dr. Edward Lebovics Discuss “Medical Halachah Annual, Volume 1: The Pandemic And Its Implications” 

Nachum Segal Network - 2/8/2023

Edward C. Halperin, M.D., M.A., chancellor and chief executive officer

Alan Kadish, M.D., president, NYMC and TU

Edward Lebovics, M.D., professor of medicine and the Sarah C. Upham professor of gastroenterology

$2.725 Million in Federal Funding Helps Launch Two Programs at New York Medical College

River Journal - 2/9/2023

Marina K. Holz, Ph.D., dean of the GSBMS, professor of cell biology and anatomy, and interim chair of the Department of Biochemistry and Molecular Biology

Robert W. Amler, M.D., M.B.A., dean of SHSP and vice president for government affairs

Faculty News

What does frostbite do to your body? Here are the gory details

FoxWeather - 2/2/2023

Ivan T. Miller, M.D., assistant professor of clinical emergency medicine

Dr. Steven Lansman to chair NYMC School of Medicine’s surgery department

Westchester & Fairfield County Business Journals - 2/3/2023

Steven L. Lansman, M.D., Ph.D., professor and chair of the Department of Surgery

Test your knowledge with a heart health quiz for ‘Go Red for Women’ Day

Pix 11 New York - 2/3/2023

Julio A. Panza, M.D., FACC, FAHA, professor of medicine and chief of the Division of Cardiology

FDA Awards Local Doctor $1.9 million for Covid Vaccine-Associated Myocarditis Research

River Journal - 2/7/2023

Supriya Jain, M.D., clinical associate professor of pediatrics and of radiology and clinical education liaison

Medical College, Medical Center Appoint Dr. Lansman to Lead Dept. of Surgery

The Examiner News - 2/9/2023

Steven L. Lansman, M.D., Ph.D., professor and chair of the Department of Surgery


Hand Hygiene Alone with Alcohol Rubs Won't Keep Patients Safe from Resistant Organisms, But Effective Innovation Has Arrived, Report Stethoscope Hygiene Experts

Yahoo Finance - 2/9/2023

Abhay Dhand, M.D., associate professor of medicine

New York Medical College is not responsible for the content

or accuracy of what may be reported in print or online media.

InTouch is New York Medical College's e-newsletter distributed to all students, faculty and staff, published during the academic year by the Office of Public Relations. Suggestions for story ideas are always welcome. Please email your comments and inquiries to Public Information Editor Lori-Ann Perrault at [email protected].

Please do not unsubscribe to this e-newsletter. Unsubscribing will remove you from all NYMC Public Relations e-mails.

Facebook  Instagram  LinkedIn  Twitter  YouTube